4//SEC Filing
GOYAL ARJUN 4
Accession 0000899243-21-022066
CIK 0001847903other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:00 PM ET
Size
22.0 KB
Accession
0000899243-21-022066
Insider Transaction Report
Form 4
GOYAL ARJUN
Director
Transactions
- Conversion
Ordinary Shares
2021-06-02+3,095,909→ 3,095,909 total(indirect: See footnote) - Conversion
Ordinary Shares
2021-06-02+85,909→ 85,909 total(indirect: See footnote) - Conversion
Series A Preferred Shares
2021-06-02−85,909→ 0 total(indirect: See footnote)→ Ordinary Shares (85,909 underlying) - Purchase
Ordinary Shares
2021-06-02$20.00/sh+729,750$14,595,000→ 3,825,659 total(indirect: See footnote) - Purchase
Ordinary Shares
2021-06-02$20.00/sh+20,250$405,000→ 106,159 total(indirect: See footnote) - Award
Series A Preferred Shares
2021-01-29$11.00/sh+3,095,909$34,054,999→ 3,095,909 total(indirect: See footnote)→ Ordinary Shares (3,095,909 underlying) - Award
Series A Preferred Shares
2021-01-29$11.00/sh+85,909$944,999→ 85,909 total(indirect: See footnote)→ Ordinary Shares (85,909 underlying) - Conversion
Series A Preferred Shares
2021-06-02−3,095,909→ 0 total(indirect: See footnote)→ Ordinary Shares (3,095,909 underlying)
Footnotes (6)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Immediately prior to the closing of the initial public offering, the Series A Preferred Shares automatically converted on a one-to-one basis into Ordinary Shares without payment or further consideration. The Series A Preferred Shares had no expiration date.
- [F3]Held by Vida Ventures II, LLC ("Vida II Main Fund"). VV Manager II, LLC ("VV Manager II") is the manager of Vida II Main Fund. The Reporting Person is a member of the investment committee of VV Manager II. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F4]Held by Vida Ventures II-A, LLC ("Vida II Parallel Fund"). VV Manager II is the manager of Vida II Parallel Fund. The Reporting Person is a member of the investment committee of VV Manager II. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F5]This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
- [F6]On May 20, 2021, the Issuer effected a share capital reorganization, which had the effect of a one for two reverse share split of the Issuer's share capital ("Share Split"). This amount has been adjusted to give effect to the Share Split.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861844
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:00 PM ET
- Size
- 22.0 KB